Medulloblastoma other diagnostic studies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of medulloblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
Bromodeoxyuridine Labeling Study
Bromodeoxyuridine Labeling Study
- Bromodeoxyuridine labeling study may be helpful in the diagnosis of medullblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
- The bromodeoxyuridine labeling index of medulloblastoma is measured between:
- 6.8 to 26.9% on dilute hydrochloric acid hydrolysis in vitro technique
- 7.5 to 28.8% on microwave heating in vitro technique
References
References
- ↑ 1.0 1.1 Onda K, Davis RL, Edwards MS (1996). “Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods”. J Neurooncol. 29 (2): 129–36. PMID 8858517.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH